A Collection of Robust Organic Synthesis Reactions for In Silico Molecule Design
暂无分享,去创建一个
Markus Hartenfeller | Gisbert Schneider | Edgar Jacoby | Steffen Renner | Martin Eberle | Peter Meier | Cristina Nieto-Oberhuber | Karl-Heinz Altmann | G. Schneider | E. Jacoby | S. Renner | K. Altmann | P. Meier | M. Hartenfeller | C. Nieto-Oberhuber | M. Eberle
[1] Markus Hartenfeller,et al. DOGS: Reaction-Driven de novo Design of Bioactive Compounds , 2012, PLoS Comput. Biol..
[2] Florian Nigsch,et al. Recent trends and observations in the design of high-quality screening collections. , 2011, Future medicinal chemistry.
[3] M Hosokawa,et al. The mammalian carboxylesterases: from molecules to functions. , 1998, Annual review of pharmacology and toxicology.
[4] Stephan C. Schürer,et al. Prospective Exploration of Synthetically Feasible, Medicinally Relevant Chemical Space , 2005, J. Chem. Inf. Model..
[5] Simon J F Macdonald,et al. Factors determining the selection of organic reactions by medicinal chemists and the use of these reactions in arrays (small focused libraries). , 2010, Angewandte Chemie.
[6] Gisbert Schneider,et al. Reaction-MQL: Line Notation for Functional Transformation , 2009, J. Chem. Inf. Model..
[7] Markus Hartenfeller,et al. Reaction-driven de novo design, synthesis and testing of potential type II kinase inhibitors. , 2011, Future medicinal chemistry.
[8] Markus Hartenfeller,et al. De novo drug design. , 2010, Methods in molecular biology.
[9] H. M. Vinkers,et al. SYNOPSIS: SYNthesize and OPtimize System in Silico. , 2003, Journal of medicinal chemistry.
[10] Allan M Jordan,et al. The medicinal chemist's toolbox: an analysis of reactions used in the pursuit of drug candidates. , 2011, Journal of medicinal chemistry.